publication venue for
- Access to the CNS: Strategies to overcome the BBB 2023
- Long-term biophysical stability of nanodiamonds combined with lipid nanocarriers for non-viral gene delivery to the retina. 1-9. 2023
- Level A IVIVC for immediate release tablets confirms in vivo predictive dissolution testing for ibuprofen.. 121415-121426. 2022
- Level A IVIVC for immediate release tablets confirms in vivo predictive dissolution testing for ibuprofen 2021
- Impact on intestinal permeability of pediatric hyperosmolar formulations after dilution: Studies with rat perfusion method.. 154-161. 2019
- Ion-pair approach coupled with nanoparticle formation to increase bioavailability of a low permeability charged drug. 36-42. 2019
- Determination of intestinal permeability using in situ perfusion model in rats: Challenges and advantages to BCS classification applied to digoxin.. 148-157. 2018
- Formulation Predictive Dissolution (fPD) Testing to Advance Oral Drug Product Development: an Introduction to the US FDA Funded '21st Century BA/BE' Project. 120-27. 2018
- Non viral vectors based on cationic niosomes as efficient gene delivery vehicles to central nervous system cells into the brain. 48-53. 2018
- Non-viral vectors based on cationic niosomes as efficient gene delivery vehicles to central nervous system cells into the brain. 48-55. 2018
- Polysorbate 20 non-ionic surfactant enhances retinal gene delivery efficiency of cationic niosomes after intravitreal and subretinal administration. 388-397. 2018
- Polysorbate 20 surfactant enhances retinal gene delivery efficiency of cationic niosomes after intravitreal and subretinal administration. 1-15. 2018
- Investigating drug absorption from the colon: Single-pass vs. Doluisio approaches to in-situ rat large-intestinal perfusion.. 135-141. 2017
- Non-viral vectors based on magnetoplexes, lipoplexes and polyplexes for VEGF gene delivery into central nervous system cell. 130-140. 2017
- Non-viral vectors based on magnetoplexes, lipoplexes and polyplexes for VEGF gene delivery into central nervous system cells. 130-140. 2017
- Segmental-dependent permeability throughout the small intestine following oral drug administration: Single-pass vs. Doluisio approach to in-situ rat perfusion.. 201-208. 2016
- In-situ intestinal rat perfusions for human F-abs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluisio experimental approaches. 1-7. 2015
- In vitro duodenal lipolysis of lipid-based drug delivery systems studied by HPLC¿UV and HPLC¿MS. 396-404. 2014
- Mathematical modelling of in situ and in vitro efflux of ciprofloxacin and grepafloxacin. 33-41. 2006
- Modelling intestinal absorption of salbutamol sulphate in rats. 735-746. 2006
- Modelling intestinal absorption of salbutamol sulphate in rats. 21-30. 2005
- Use of molecular topology for the prediction of physico-chemical, pharmacokinetic and toxicological properties of a group of antihistaminic drugs.. 111-119. 2002